ACCESSION: MSBNK-SMB_Measured-HSA015P0110033
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 14
COMMENT: RAW_SPEC {'EL23_pos_10671': {'bp': 264323.0, 'sum': 840062.0}, 'EL17_pos_10581': {'bp': 121051.0, 'sum': 582105.0}, 'EL10_pos_10695': {'bp': 164056.0, 'sum': 706749.0}, 'EL08_pos_10713': {'bp': 108535.0, 'sum': 539659.0}, 'Blanc1-pos_10928': {'bp': 170413.0, 'sum': 647558.0}, 'EL19_pos_10515': {'bp': 87674.0, 'sum': 481085.0}, 'EL09_pos_10655': {'bp': 140033.0, 'sum': 645886.0}, 'EL17_pos_10697': {'bp': 198256.0, 'sum': 837509.0}, 'EL19_pos_10738': {'bp': 131115.0, 'sum': 605815.0}, 'Blanc2-pos_10593': {'bp': 129706.0, 'sum': 528481.0}, 'EL22_pos_10766': {'bp': 213294.0, 'sum': 918358.0}, 'EL07_pos_10659': {'bp': 116323.0, 'sum': 528600.0}, 'EL13_pos_10671': {'bp': 178499.0, 'sum': 701253.0}, 'EL04_pos_10634': {'bp': 127363.0, 'sum': 612115.0}}
COMMENT: RETENTION_TIME_STDEV 0.118
COMMENT: PRECURSOR_M/Z_RAW 110.071692
COMMENT: PRECURSOR_M/Z_STDEV 0.000033
COMMENT: PRECURSOR_IN_MS1 mz 110.071241; int 55.084; delta(ppm) 0.639931
COMMENT: PROPOSED_CHARGE_STATE +1; mz 111.074593; int 2.874; cor 0.793
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+H; M+CH3OH+H; mz 142.097636; int 3.093; cor 0.654
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.275; C5H7N3; [M+H]+; delta(ppm) -0.275068
COMMENT: PROPOSED_MF MS-FINDER 3.602; C5H7N3; [M+H]+; delta(ppm) -0.278705
COMMENT: PROPOSED_MF SIRIUS5_Sirius 3.420; C5H7N3; [M+H]+; delta(ppm) -0.278705
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C5H7N3; [M+H]+; delta(ppm) -0.278705
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.810; C5H7N3; [M+H]+; delta(ppm) -0.278705
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.365; C2H8FN3O; [M+H]+; delta(ppm) -10.659631
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.815; C7H9O; [M+H]+; delta(ppm) -12.476682
COMMENT: PROPOSED_MF SIRIUS6_Sirius -5.015; CH10N4P; [M+H]+; delta(ppm) -3.086905
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.999; C5H7N3; [M+H]+; delta(ppm) -0.278705
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.001; C2H8FN3O; [M+H]+; delta(ppm) -10.659631
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.667; IFFLKGMDBKQMAH-UHFFFAOYSA-N; [M+H]+; NC1=CC(N)=NC=C1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.619; XVEVWOAHSYZRQE-UHFFFAOYSA-N; [M+H]+; NC(=N)C1=CNC=C1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.619; OYTKINVCDFNREN-UHFFFAOYSA-N; [M+H]+; NC1=CC=NC=C1N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.556; NWELCUKYUCBVKK-UHFFFAOYSA-N; [M+H]+; C1=CC=NC(=C1)NN
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.556; GHCFWKFREBNSPC-UHFFFAOYSA-N; [M+H]+; N=1C=CC(=NC1N)C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.782; XVEVWOAHSYZRQE-UHFFFAOYSA-N; [M+H]+; Brunfelsamidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.512; IFFLKGMDBKQMAH-UHFFFAOYSA-N; [M+H]+; 2,4-diaminopyridine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.512; OYTKINVCDFNREN-UHFFFAOYSA-N; [M+H]+; amifampridine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.460; NWELCUKYUCBVKK-UHFFFAOYSA-N; [M+H]+; pyridin-2-ylhydrazine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.460; GHCFWKFREBNSPC-UHFFFAOYSA-N; [M+H]+; 4-methylpyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.460; QLILMARGWDFNHA-UHFFFAOYSA-N; [M+H]+; 1-(3H-pyrrol-3-ylidene)methanediamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; GHCFWKFREBNSPC-UHFFFAOYSA-N; [M+H]+; 4-methylpyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.439; IFFLKGMDBKQMAH-UHFFFAOYSA-N; [M+H]+; 2,4-diaminopyridine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.439; OYTKINVCDFNREN-UHFFFAOYSA-N; [M+H]+; amifampridine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.366; QLILMARGWDFNHA-UHFFFAOYSA-N; [M+H]+; 1-(3H-pyrrol-3-ylidene)methanediamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.326; XVEVWOAHSYZRQE-UHFFFAOYSA-N; [M+H]+; Brunfelsamidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.326; NWELCUKYUCBVKK-UHFFFAOYSA-N; [M+H]+; pyridin-2-ylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.928; OYTKINVCDFNREN-UHFFFAOYSA-N; [M+H]+; pyridine-3,4-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.232; VHNQIURBCCNWDN-UHFFFAOYSA-N; [M+H]+; pyridine-2,6-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.387; ZZYXNRREDYWPLN-UHFFFAOYSA-N; [M+H]+; pyridine-2,3-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.327; KPMVHELZNRNSMN-UHFFFAOYSA-N; [M+H]+; 2,3-dihydro-1H-imidazo[1,2-b]pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.296; GHCFWKFREBNSPC-UHFFFAOYSA-N; [M+H]+; 4-methylpyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.184; MIROPXUFDXCYLG-UHFFFAOYSA-N; [M+H]+; pyridine-2,5-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.168; ZWZXPQUCMIIDTF-UHFFFAOYSA-N; [M+H]+; 3,4-dihydro-2H-pyrrol-5-ylcyanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.141; OEJCZBUJXIJRST-UHFFFAOYSA-N; [M+H]+; 2-aminopentanedinitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.932; MHZNCOBCMWBPPM-UHFFFAOYSA-N; [M+H]+; 5-methylpyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.898; NWELCUKYUCBVKK-UHFFFAOYSA-N; [M+H]+; pyridin-2-ylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.897; GKVDLTTVBNOGNJ-UHFFFAOYSA-N; [M+H]+; 2-methylpyrimidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.879; NDPKVJZZCMFBIO-UHFFFAOYSA-N; [M+H]+; 5-methylpyridazin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.877; LAERIBHKDNBVOO-UHFFFAOYSA-N; [M+H]+; 6-methylpyrimidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.868; BCPGZEVUJXKIHK-UHFFFAOYSA-N; [M+H]+; pyridazin-3-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.864; SEQBQXBBDMPPPX-UHFFFAOYSA-N; [M+H]+; pyridazin-4-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.863; XSCYITPLDKUZJB-UHFFFAOYSA-N; [M+H]+; 5-methylpyrimidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.862; IYYGTADJURIVJO-UHFFFAOYSA-N; [M+H]+; N-methylpyridazin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.862; WDTVJTBXOFGSJT-UHFFFAOYSA-N; [M+H]+; 4-methylpyridazin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.859; JFCCKHKTRIBJEM-UHFFFAOYSA-N; [M+H]+; 3-methylpyridazin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.858; VINQTTYFIBEQCY-UHFFFAOYSA-N; [M+H]+; 6-methylpyridazin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.851; AUHXBTKGPUVFCB-UHFFFAOYSA-N; [M+H]+; pyrimidin-4-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.847; USRYWZFLGFQQEB-UHFFFAOYSA-N; [M+H]+; pyrimidin-5-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.838; IFFLKGMDBKQMAH-UHFFFAOYSA-N; [M+H]+; pyridine-2,4-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.837; LOSIUHLAYNGOTD-UHFFFAOYSA-N; [M+H]+; 4-cyclopropyl-2H-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.834; QWVLIXTUCFAPFH-UHFFFAOYSA-N; [M+H]+; 5-methylpyridazin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.807; CVRWHBCQJCUBFE-UHFFFAOYSA-N; [M+H]+; 1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.802; ISIOZKZXXAFJTG-UHFFFAOYSA-N; [M+H]+; 2,3-dihydro-1H-imidazo[1,2-a]imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.796; BMHJVMAHIYFSOF-UHFFFAOYSA-N; [M+H]+; 4-cyclopropyl-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.735; DHSAAWDYDOKDGX-UHFFFAOYSA-N; [M+H]+; 1,4,5,6-tetrahydropyrrolo[3,4-d]imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.650; ABYXFACYSGVHCW-UHFFFAOYSA-N; [M+H]+; pyridine-3,5-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.590; KAZMCIGKULUUMR-UHFFFAOYSA-N; [M+H]+; 6-methylpyridazin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.574; BQNXHDSGGRTFNX-UHFFFAOYSA-N; [M+H]+; N-methylpyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.554; KRTLKPFLTASKCG-UHFFFAOYSA-N; [M+H]+; pyridin-4-ylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.535; VERCQLOBLOLFMW-UHFFFAOYSA-N; [M+H]+; N-methylpyrimidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.528; TWLUCQHODWVRCF-UHFFFAOYSA-N; [M+H]+; N-methylpyridazin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.478; ROSKZJGILXBSFM-UHFFFAOYSA-N; [M+H]+; pyrimidin-2-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.468; RCIGDGBXEMECGY-UHFFFAOYSA-N; [M+H]+; pyridin-3-ylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.468; ZNQOALAKPLGUPH-UHFFFAOYSA-N; [M+H]+; 5-methylpyrazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.468; HQIBSDCOMQYSPF-UHFFFAOYSA-N; [M+H]+; pyrazin-2-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.450; UAOOJJPSCLNTOP-UHFFFAOYSA-N; [M+H]+; 6-methylpyrazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.450; VGKOARVVEXZTPU-UHFFFAOYSA-N; [M+H]+; N-methylpyrazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.445; VQPHZDDLWFHRHR-UHFFFAOYSA-N; [M+H]+; 3-methylpyrazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.440; VGPRNGGSKJHOFE-UHFFFAOYSA-N; [M+H]+; 2-methylpyrimidin-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.393; KTIRQJGWLMORDV-UHFFFAOYSA-N; [M+H]+; 5-cyclopropyl-1H-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -55.445; GKVDLTTVBNOGNJ; [M+H]+; 2-methyl-4-pyrimidinamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -62.298; GHCFWKFREBNSPC; [M+H]+; 4-Methyl-2-pyrimidinamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -62.320; BQNXHDSGGRTFNX; [M+H]+; 2-Methylaminopyrimidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -66.688; ROSKZJGILXBSFM; [M+H]+; zlchem 1187
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -75.637; LAERIBHKDNBVOO; [M+H]+; Ambcb9072006
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -76.792; MHZNCOBCMWBPPM; [M+H]+; 5-methyl-2-pyrimidinamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -78.222; ZNQOALAKPLGUPH; [M+H]+; 5-methyl-2-pyrazinamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -84.969; UAOOJJPSCLNTOP; [M+H]+; 6-methylpyrazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -86.321; VGPRNGGSKJHOFE; [M+H]+; 2-Methyl-5-pyrimidinamin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -94.565; HQIBSDCOMQYSPF; [M+H]+; 2-Aminomethylpyrazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -114.482; XVEVWOAHSYZRQE; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -120.735; IFFLKGMDBKQMAH; [M+H]+; 2,4-Diaminopyridine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -122.275; VHNQIURBCCNWDN; [M+H]+; DAP (amine)
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -140.567; MIROPXUFDXCYLG; [M+H]+; 2,5-Pyridinediamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -142.560; ZZYXNRREDYWPLN; [M+H]+; Pyridinediamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -147.778; ABYXFACYSGVHCW; [M+H]+; 3,5-Diaminopyridine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -162.410; OYTKINVCDFNREN; [M+H]+; 3,4 Diaminopyridine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -166.480; NDPKVJZZCMFBIO; [M+H]+; 5-Methyl-3-pyridazinamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -168.579; KAZMCIGKULUUMR; [M+H]+; 6-Methylpyridazin-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -169.474; BCPGZEVUJXKIHK; [M+H]+; 3-Aminomethylpyridazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -180.248; NWELCUKYUCBVKK; [M+H]+; Enamine_005250
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -185.451; KRTLKPFLTASKCG; [M+H]+; 4-pyridylhydrazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -192.741; KPMVHELZNRNSMN; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -196.439; RCIGDGBXEMECGY; [M+H]+; Ambcb4019584
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -234.526; ZWZXPQUCMIIDTF; [M+H]+; 2-(N-Cyanimino)pyrrolidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.357; GKVDLTTVBNOGNJ; [M+H]+; 2-methyl-4-pyrimidinamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -64.603; GKVDLTTVBNOGNJ; [M+H]+; 2-Methylpyrimidin-4-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -72.160; LAERIBHKDNBVOO; [M+H]+; 6-methyl-N-tritiopyrimidin-4-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -73.142; ROSKZJGILXBSFM; [M+H]+; 2-Pyrimidinemethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -75.154; VGPRNGGSKJHOFE; [M+H]+; 2-Methylpyrimidin-5-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -80.206; USRYWZFLGFQQEB; [M+H]+; 5-Pyrimidinemethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -82.707; GHCFWKFREBNSPC; [M+H]+; 4-methylpyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -89.305; BQNXHDSGGRTFNX; [M+H]+; 2-Methylaminopyrimidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -89.466; UAOOJJPSCLNTOP; [M+H]+; 6-Methylpyrazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -95.000; VGKOARVVEXZTPU; [M+H]+; N-methylpyrazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -97.042; AUHXBTKGPUVFCB; [M+H]+; Pyrimidin-4-ylmethylazanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.466; GKVDLTTVBNOGNJ; [M+H]+; 2-Methylpyrimidin-4-amine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C5H8N3; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 17.374
MS$FOCUSED_ION: PRECURSOR_M/Z 110.071243
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-03di-4900000000-cd5a7bb823f856aa77fe
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  55.0544349 85.7605 55.055143 0.7629 30.54 0.4328 11 f{C4H7}/3.78ppm,p-C1H1N3
  68.0495426 150.9735 68.050285 1.0581 37.63 0.6000 14 f{C4H6N1}/0.98ppm,p-C1H2N2
  69.0448193 119.7694 69.045562 1.3470 31.71 0.6538 13 f{C3H5N2}/1.37ppm,p-C2H3N1
  70.0652381 247.4930 70.065981 1.3559 83.27 0.6176 14 f{C4H8N1}/1.60ppm,p-C1N2
  77.9988093 95.3188 77.999544 1.2949 44.13 0.2000 10 ?
  87.0040734 261.3664 87.004776 0.9770 70.94 0.4110 14 ?
  88.0041946 255.7963 88.004892 1.0454 87.06 -0.0420 12 ?
  109.0760376 116.5469 109.076566 1.5219 39.33 0.5273 11 ?
  110.0712947 999.0000 110.071816 0.5814 0.00 1.0000 14 f{C5H8N3}/0.19ppm,p
  111.0916757 660.1992 111.092190 1.0442 151.03 0.7231 14 ?
  112.0869576 133.9299 112.087464 1.0438 32.75 0.5736 14 ?
  113.9635957 265.6000 113.964088 0.6669 85.84 0.2033 13 ?
  115.9640501 138.6272 115.964525 0.7416 49.68 0.2182 11 ?
PK$NUM_PEAK: 13
PK$PEAK: m/z int. rel.int.
  55.054435 85.76 85
  68.049543 150.97 150
  69.044819 119.77 119
  70.065238 247.49 247
  77.998809 95.32 95
  87.004073 261.37 261
  88.004195 255.80 255
  109.076038 116.55 116
  110.071295 999.00 999
  111.091676 660.20 660
  112.086958 133.93 133
  113.963596 265.60 265
  115.964050 138.63 138
//
